Green Cross remarkably grew up in first half of 2005.

Green Cross reported 155,651 MW of sales during the first half of this year, 15.2 BW of operating income, 26,670 MW of ordinary income and 18.7 BW of net income, largely led by the sales of blood preparations at 70,354 MW and vaccines at 21,541 MW as well as OTC drugs like Zenol at 21,889 MW and diagnostic products at 7,550 MW.

The sales increases showed OTC drugs from 16,592 MW in 2004 to 2...